Inadequate information about pregnancy is common among young women with spinal cord injury. Heightened surveillance for certain complications is warranted in women with spinal cord injuries.
Prenatal sonographic features are related to postnatal outcome. Persistently isolated intra-abdominal calcifications have an excellent outcome. Delivery in a tertiary care center is recommended when calcifications are associated with other sonographic findings.
The ORACLE II study published in 2001 compared use of amoxicillin-clavulanate (co-amoxiclav) and/or erythromycin, with placebo in women with spontaneous preterm labor (SPL) and intact membranes who had no clinical signs of infection, to determine whether these antibiotics could prevent or eliminate perinatal infections presumed to have a causative role in SPL. Neither drug produced any improvement in neonatal mortality or morbidity. The present study, the ORACLE Children Study II (OCS II), assessed long-term outcomes for 4473 children age 7 years, born in the United Kingdom to 4221 women enrolled in the original ORACLE II trial. The mothers completed a detailed structured questionnaire to assess the health status of the children. The primary outcome was the overall level of functional impairment (mild, moderate, or severe). Results from national curriculum tests assessed the education outcome. Follow-up data was obtained for 3196 of the 4473 children (71%).Compared to mothers who had received no erythromycin, more children born to mothers who had received any erythromycin (with or without co-amoxiclav) had any functional impairment: erythromycin (658 [42.3%] of 1554 children) versus no erythromycin (574 [38.3%] of 1498); odds ratio (OR) 1.18, 95% confidence interval (CI) 1.02-1.37. In contrast, there was no difference in the proportion of children whose mothers had received co-amoxiclav (with or without erythromycin) and those whose mothers had not received co-amoxiclav. More children whose mothers had received any erythromycin presented with bowel disorders. A higher proportion of children whose mothers had received either antibiotic developed cerebral palsy compared to those born to mothers who had not received these antibiotics: erythromycin (53 [3.3%] of 1611) versus no erythromycin (27 [1.7%] of 1562), OR 1.93, 95% CI 1.21-3.09; and co-amoxiclav (50 [3.2%] of 1587) versus no co-amoxiclav (30 [1.9%] of 1586), OR 1.69, 95% CI 1.07-2.67. With these two exceptions, neither antibiotic had effects on other medical conditions, or on the number of deaths, behavior, or educational attainment. The investigators conclude that these findings support the viewpoint that antibiotics are not advisable in SPL without clinical signs of infection. EDITORIAL COMMENT(When used for the prevention of preterm birth, antibiotics have for the most part been a disappointment. With few exceptions, this assessment applies whether they were studied before or after the onset of preterm labor. Large randomized trials failed to confirm the promise of screening and treating asymptomatic bacterial vaginosis or trichomonas in the mid-trimester (Carey JC, et al. NEJM 2000;342:534 and Klebanoff MA, et al. NEJM 2001;345:487) and failed to demonstrate a benefit to treating asymptomatic women with a positive mid-pregnancy cervico- OBSTETRICS Volume 64, Number 3 OBSTETRICAL AND GYNECOLOGICAL SURVEY ABSTRACTOf the estimated 20,000 American women between the ages of 16 and 30 years who have spinal cord injuries, nearly 14% will have at least one subs...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.